GNH USA

Europe — EMA

Injexate

GNH USA supplies Injexate (Methotrexate), a antimetabolite immunosuppressant for rheumatoid arthritis, psoriasis, certain cancers and Crohn's disease.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Injexate, is an antimetabolite (folate antagonist) presented as an injection for subcutaneous use. It treats rheumatoid arthritis, psoriasis, certain cancers and Crohn's disease in appropriate patients.

GNH USA supplies Injexate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate is employed in autoimmune and oncologic conditions that involve rapid cell proliferation or immune activation.

Rheumatoid arthritis: reduces joint inflammation and slows disease progression. Psoriasis: improves skin lesions and reduces severity. Certain cancers (e.g., leukemia, lymphoma): inhibits tumor cell growth. Crohn's disease: induces remission and reduces intestinal inflammation.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting. - Fatigue or general weakness. - Mouth sores (stomatitis). - Mild elevation of liver enzymes.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Bone marrow suppression leading to pancytopenia.

What precautions apply to Methotrexate?

When using Injexate, several safety considerations should be observed.

Monitor liver function: perform regular liver enzyme tests. Assess blood counts: watch for cytopenias and anemia. Evaluate renal function: adjust dosing if kidney impairment is present. Avoid use in pregnancy: contraindicated unless benefits outweigh risks. Screen for infections: ensure no active infections before initiation. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate interacts with several medications that may alter its safety or efficacy.

Major Interactions (Avoid): - NSAIDs: increase risk of renal toxicity. - Live vaccines: heightened risk of infection. - Alcohol: exacerbates hepatotoxicity.

Moderate Interactions (Monitor Closely): - Azathioprine: may enhance myelosuppression. - Warfarin: can alter INR and bleeding risk. - Proton pump inhibitors: possible increase in methotrexate plasma levels.

Frequently asked questions

What conditions is Injexate used for?+
Injexate, containing methotrexate, is prescribed for rheumatoid arthritis, psoriasis, certain cancers such as leukemia and lymphoma, and Crohn's disease. It works by suppressing immune activity and inhibiting rapid cell growth, helping to control inflammation and tumor progression.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for producing tetrahydrofolate, a cofactor in DNA synthesis. By limiting nucleotide formation, it reduces the proliferation of immune cells and cancer cells, and also increases adenosine levels that help dampen inflammation.
What is the usual dose of Injexate?+
The specific dose of Injexate is determined by the prescribing clinician based on the patient’s condition, weight, renal function, and treatment response. Dosage regimens can vary widely, and the prescriber will tailor the schedule to achieve optimal therapeutic effect while monitoring safety.
Is Injexate safe to use during pregnancy or breastfeeding?+
Methotrexate is generally contraindicated during pregnancy because it can cause fetal harm. Women of child‑bearing potential should use effective contraception. Limited data exist for breastfeeding, and the drug may be excreted in milk, so breastfeeding is usually discouraged unless the benefits outweigh the risks.
How do I order Injexate from GNH USA?+
To order Injexate, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Injexate compare with other immunosuppressants?+
Compared with biologic agents, methotrexate is a small‑molecule drug that is less expensive and can be administered subcutaneously. It has a well‑established efficacy profile for autoimmune diseases but may require more laboratory monitoring for liver and blood‑cell effects. Biologics often have different safety considerations, such as infection risk.
What are the storage and handling requirements for Injexate?+
Injexate should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain stability and ensure proper temperature control during transport and storage.
How is Injexate administered?+
Injexate is given by subcutaneous injection, typically into the abdomen or thigh. The injection site should be rotated to reduce irritation, and the medication must be prepared according to aseptic technique. Administration is performed by a healthcare professional or trained patient under medical supervision.
What are the most serious risks associated with Injexate?+
The most serious risks include severe liver toxicity, pulmonary fibrosis, and bone‑marrow suppression leading to pancytopenia. Patients should be monitored regularly for liver enzymes, respiratory symptoms, and complete blood counts to detect these complications early.
Who should not use Injexate?+
Injexate should not be used by individuals with known hypersensitivity to methotrexate, severe renal or hepatic impairment, active infections, or those who are pregnant or planning pregnancy without adequate contraception. Caution is also advised for patients with pre‑existing blood‑cell disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Accord Healthcare B.V.
Origin
EU

Related products